Scott Galloway on Tesla and SpaceX: “Tesla’s the Patient and SpaceX Is the Organ Donor”
Key TakeawaysBarclays upgraded Tesla to Overweight on Monday, raised its price target to $450 from $370, and called a SpaceX merger a key part of the bull case. Scott Galloway argues the merger would be a bailout in which Tesla holders win and SpaceX holders pay.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo